PRUITT MICHAEL D (CEO, Chairman) purchased 3.2% of their position (105.00 shares) of SONNET BIOTHERAPEUTICS HOLDINGS, INC. on the open market
Open‑market purchase worth $117.60 — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/31/2019ACC: 0001493152-19-011396
DirectorOfficer· CEO, Chairman
Since Aug 2018
+105.00
Net shares
Net buyer
$117.60
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
105.00 acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+105.00
Price / share
$1.12
Trade value
$117.60
% of position
3.2%
7/30/2019
3.25K→3.36K
Total
Net shares
+105.00
Net value
$117.60
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/30/2019 | P · Purchase | +105.00 | $1.12 | $117.60 | 3.2% | 3.25K | 3.36K |
| Total | +105.00 | $117.60 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned25.96K
Common Stock
DirectShares owned17.26K
Series 1 Preferred Stock
IndirectShares owned330.00
Total
17.26K direct·26.29K indirect43.55K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25.96K | Indirect |
| Common Stock | 17.26K | Direct |
| Series 1 Preferred Stock | 330.00 | Indirect |
| Total | 43.55K | 17.26K direct·26.29K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported